Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.05
-0.46 (-1.33%)
At close: Jul 20, 2026, 4:00 PM EDT
34.06
+0.01 (0.03%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $24.49 billion as of July 20, 2026. Its market cap has increased by 214.92% in one year.
Market Cap
24.49B
Enterprise Value
20.31B
1-Year Change
214.92%
Ranking
Category
Stock Price
$34.05
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $24.49B, an increase of 4,491.72%. That is a compound annual growth rate of 97.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 24.49B | 62.28% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 39.58B |
| Alnylam Pharmaceuticals | 35.71B |
| BeOne Medicines AG | 34.69B |
| Royalty Pharma | 33.50B |
| Moderna | 24.53B |
| Insmed | 23.48B |
| Incyte | 23.42B |
| BioNTech SE | 23.13B |